Table of Contents
1 Industry Overview of Deferiprone
1.1 Definition and Specifications of Deferiprone
1.1.1 Definition of Deferiprone
1.1.2 Specifications of Deferiprone
1.2 Classification of Deferiprone
1.3 Applications of Deferiprone
1.3.1 Nuclear Application
1.3.2 Non-Nuclear Application
1.4 Industry Chain Structure of Deferiprone
1.5 Industry Overview and Major Regions Status of Deferiprone
1.5.1 Industry Overview of Deferiprone
1.5.2 Global Major Regions Status of Deferiprone
1.6 Industry Policy Analysis of Deferiprone
1.7 Industry News Analysis of Deferiprone
2 Manufacturing Cost Structure Analysis of Deferiprone
2.1 Raw Material Suppliers and Price Analysis of Deferiprone
2.2 Equipment Suppliers and Price Analysis of Deferiprone
2.3 Labor Cost Analysis of Deferiprone
2.4 Other Costs Analysis of Deferiprone
2.5 Manufacturing Cost Structure Analysis of Deferiprone
2.6 Manufacturing Process Analysis of Deferiprone
3 Technical Data and Manufacturing Plants Analysis of Deferiprone
3.1 Capacity and Commercial Production Date of Global Deferiprone Major Manufacturers in 2023
3.2 Manufacturing Plants Distribution of Global Deferiprone Major Manufacturers in 2023
3.3 R&D Status and Technology Source of Global Deferiprone Major Manufacturers in 2023
3.4 Raw Materials Sources Analysis of Global Deferiprone Major Manufacturers in 2023
4 Capacity, Production and Revenue Analysis of Deferiprone by Regions, Types and Manufacturers
4.1 Global Capacity, Production and Revenue of Deferiprone by Regions 2019-2024
4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Deferiprone 2019-2024
4.3 Global Capacity, Production and Revenue of Deferiprone by Types 2019-2024
4.4 Global Capacity, Production and Revenue of Deferiprone by Manufacturers 2019-2024
5 Price, Cost, Gross and Gross Margin Analysis of Deferiprone by Regions, Types and Manufacturers
5.1 Price, Cost, Gross and Gross Margin Analysis of Deferiprone by Regions 2019-2024
5.2 Price, Cost, Gross and Gross Margin Analysis of Deferiprone by Types 2019-2024
5.3 Price, Cost, Gross and Gross Margin Analysis of Deferiprone by Manufacturers 2019-2024
6 Consumption Volume, Consumption Value and Sale Price Analysis of Deferiprone by Regions, Types and Applications
6.1 Global Consumption Volume and Consumption Value of Deferiprone by Regions 2019-2024
6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Deferiprone 2019-2024
6.3 Global Consumption Volume and Consumption Value of Deferiprone by Types 2019-2024
6.4 Global Consumption Volume and Consumption Value of Deferiprone by Applications 2019-2024
6.5 Sale Price of Deferiprone by Regions 2019-2024
6.6 Sale Price of Deferiprone by Types 2019-2024
6.7 Sale Price of Deferiprone by Applications 2019-2024
6.8 Market Share Analysis of Deferiprone by Different Sale Price Levels
7 Supply, Import, Export and Consumption Analysis of Deferiprone
7.1 Supply, Consumption and Gap of Deferiprone 2019-2024
7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2019-2024
7.3 USA Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2019-2024
7.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2019-2024
7.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2019-2024
7.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2019-2024
8 Major Manufacturers Analysis of Deferiprone
8.1 Manufacturer One
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Capacity, Production, Price, Cost, Gross and Revenue
8.1.4 Contact Information
8.2 Manufacturer Two
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Capacity, Production, Price, Cost, Gross and Revenue
8.2.4 Contact Information
8.3 Manufacturer Three
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Capacity, Production, Price, Cost, Gross and Revenue
8.3.4 Contact Information
8.4 Manufacturer Four
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Capacity, Production, Price, Cost, Gross and Revenue
8.4.4 Contact Information
8.5 Manufacturer Five
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Capacity, Production, Price, Cost, Gross and Revenue
8.5.4 Contact Information
…
9 Marketing Trader or Distributor Analysis of Deferiprone
9.1 Marketing Channels Status of Deferiprone
9.2 Traders or Distributors with Contact Information of Deferiprone by Regions
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Deferiprone
9.4 Regional Import, Export and Trade Analysis of Deferiprone
10 Industry Chain Analysis of Deferiprone
10.1 Upstream Major Raw Materials Suppliers Analysis of Deferiprone
10.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Deferiprone
10.1.2 Major Raw Materials Suppliers with Supply Volume Analysis of Deferiprone by Regions
10.2 Upstream Major Equipment Suppliers Analysis of Deferiprone
10.2.1 Major Equipment Suppliers with Contact Information Analysis of Deferiprone
10.2.2 Major Equipment Suppliers with Product Pictures Analysis of Deferiprone by Regions
10.3 Downstream Major Consumers Analysis of Deferiprone
10.3.1 Major Consumers with Contact Information Analysis of Deferiprone
10.3.2 Major Consumers with Consumption Volume Analysis of Deferiprone by Regions
10.4 Supply Chain Relationship Analysis of Deferiprone
11 Development Trend of Analysis of Deferiprone
11.1 Capacity, Production and Revenue Forecast of Deferiprone by Regions and Types
11.1.1 Global Capacity, Production and Revenue of Deferiprone by Regions 2024-2029
11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Deferiprone 2024-2029
11.1.3 Global Capacity, Production and Revenue of Deferiprone by Types 2024-2029
11.2 Consumption Volume and Consumption Value Forecast of Deferiprone by Regions, Types and Applications
11.2.1 Global Consumption Volume and Consumption Value of Deferiprone by Regions 2024-2029
11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Deferiprone 2024-2029
11.2.3 Global Consumption Volume and Consumption Value of Deferiprone by Types 2024-2029
11.2.4 Global Consumption Volume and Consumption Value of Deferiprone by Applications 2024-2029
11.3 Supply, Import, Export and Consumption Forecast of Deferiprone
11.3.1 Supply, Consumption and Gap of Deferiprone 2024-2029
11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2024-2029
11.3.3 USA Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2024-2029
11.3.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2024-2029
11.3.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2024-2029
11.3.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Deferiprone 2024-2029
12 New Project Investment Feasibility Analysis of Deferiprone
12.1 New Project SWOT Analysis of Deferiprone
12.2 New Project Investment Feasibility Analysis of Deferiprone
13 Conclusion of the Global Deferiprone (CAS 30652-11-0) Industry 2024 Market Research Report
※参考情報 デフェリプロン(Deferiprone)は、化学式C7H9N3O5Sの化合物で、CAS番号30652-11-0で示される薬剤です。特に鉄過剰症の治療に用いられる成人および小児向けの薬剤として知られています。デフェリプロンは、鉄キレート剤の一種であり、体内の過剰な鉄を除去するために重要な役割を果たします。ここでは、デフェリプロンの定義、特徴、用途、および関連技術について詳述します。 デフェリプロンは1970年代に開発され、当初は多くの鉄蓄積疾患に対して効果があるとされました。主に、βサラセミア患者や他の鉄過剰症を持つ患者に使用されます。これらの疾患では、頻繁な輸血によって体内に蓄積される鉄が健康に悪影響を及ぼすため、鉄の排出を促進することが求められます。 この薬剤の特徴としては、まずその選択性と効率性が挙げられます。デフェリプロンは、鉄と特異的に結合する性質があり、これにより体内の鉄を効果的にキレートし、排出することが可能です。また、経口投与が可能であるため、患者が自己管理しやすいという利点もあります。医療現場においても、デフェリプロンは比較的簡便な治療法として評価されています。 デフェリプロンにはいくつかのバリエーションがあります。特に注目されているのは、モノホスファート塩形態と呼ばれる製剤です。この形態では、デフェリプロンが単体で存在し、高い安定性と生物学的利用能を持っています。これにより、治療効果の向上が期待されています。 デフェリプロンの主な用途は、鉄過剰症の治療にありますが、その適応症はβサラセミアだけに限らず、血液疾患や慢性肝疾患、さらには一部の心疾患においても利用されることがあります。実際、デフェリプロンは輸血に依存する患者において、鉄負荷を軽減し、合併症のリスクを低下させることに寄与しています。また、鉄過剰症のその他の形態や、ある種の遺伝的疾患にも対応できる可能性があります。 さらに、デフェリプロンは他の鉄キレート剤と併用されることもあります。例えば、デフェラシロクスやデフェラリプロンといった他の治療薬と組み合わせることで、より良い治療効果を得ることができる場合があります。これにより、鉄の排出効率が向上し、長期的な健康管理につながるのです。 デフェリプロンの関連技術については、主に鉄キレート反応のメカニズムが注目されています。薬理学的な観点から、デフェリプロンは体内の鉄と結びつき、そのまま腎臓を通じて体外に排出される仕組みを持っています。このメカニズムは、生化学的には非常に興味深く、他の金属イオンとも相互作用する可能性があります。最近の研究では、デフェリプロンのメカニズムをさらに理解するための新たな技術が開発されつつあり、より効果的な治療戦略が模索されています。 使用上の注意点として、デフェリプロンは副作用が報告されています。具体的には、消化器系の不調や白血球数の減少が見られることがあります。患者においては、定期的な血液検査が推奨されており、必要に応じて投与量の調整が行われます。このように、患者に合わせた治療が求められるため、医療従事者との密接なコミュニケーションが必要不可欠です。 総じて、デフェリプロンは鉄過剰症に対する有効な治療薬であり、その進展は患者のQOL(クオリティ・オブ・ライフ)の向上を目指しています。今後の研究により、さらなる適応症の拡大や副作用の軽減が期待され、より多くの患者に恩恵をもたらす可能性があります。このように、デフェリプロンは現代医療において重要な役割を果たし続けることでしょう。 |